Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GLIOBLASTOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GLIOBLASTOMA is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, ALZHEIMER'S DISEASE, Aging. Connected to 605 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | GLIOBLASTOMA |
| Associated Diseases | Aging, Als, Alzheimer, Breast Cancer, Cancer |
| Known Drugs/Compounds | TEMOZOLOMIDE |
| Interactions | Actin, ADSL, AGING, AKT, ALDH1A3, ALS |
| KG Connections | 1389 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
graph TD
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| MITOCHONDRIA["MITOCHONDRIA"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| Tumor["Tumor"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| Glioblastoma["Glioblastoma"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"activates"| Cancer["Cancer"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"expressed in"| Parkinson["Parkinson"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"expressed in"| Glioblastoma_1["Glioblastoma"]
PI3K_AKT_MTOR_PATHWAY["PI3K_AKT_MTOR_PATHWAY"] -->|"activates"| GLIOBLASTOMA["GLIOBLASTOMA"]
MTOR["MTOR"] -->|"activates"| GLIOBLASTOMA["GLIOBLASTOMA"]
AUTOPHAGY["AUTOPHAGY"] -->|"co discussed"| GLIOBLASTOMA["GLIOBLASTOMA"]
ALZHEIMER["ALZHEIMER"] -->|"co discussed"| GLIOBLASTOMA["GLIOBLASTOMA"]
style GLIOBLASTOMA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Glioblastoma | associated_with | disease | 1.00 |
| Glioma | associated_with | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Glioma | activates | disease | 1.00 |
| Glioblastoma | inhibits | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Glioblastoma | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Glioblastoma | regulates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Glioblastoma | activates | disease | 1.00 |
| immunosuppressive microenvironment | associated_with | phenotype | 0.95 |
| blood-brain barrier | involves | pathway | 0.90 |
| Cranial Bone Marrow | associated_with | cell_type | 0.90 |
| neural stem cells | affects | cell_type | 0.90 |
| lipid metabolism | activates | process | 0.90 |
| oxidative stress response | involves | pathway | 0.90 |
| neurons | affects | cell_type | 0.90 |
| blood-brain barrier | affects | brain_region | 0.90 |
| PI3K-AKT-mTOR signaling | involves | pathway | 0.90 |
| macrophages | affects | cell_type | 0.90 |
| Brain Tumor | associated_with | disease | 0.90 |
| unfolded protein response | involves | pathway | 0.90 |
| Mtor | activates | pathway | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| MTOR | activates | gene | 0.90 |
| Mtor | activates | pathway | 0.90 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| Glioma | therapeutic_target | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Als | regulates | disease | 0.85 |
| Glioma | regulates | disease | 0.85 |
| Cancer | associated_with | disease | 0.85 |
| Glioblastoma | treats | disease | 0.85 |
| Tumor | treats | disease | 0.85 |
| Therapy Resistance | associated_with | phenotype | 0.85 |
| Circadian Rhythms | interacts_with | process | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| astrocytes | affects | cell_type | 0.80 |
| ubiquitin-proteasome | involves | pathway | 0.80 |
| Immunosuppression | associated_with | phenotype | 0.80 |
| Metabolic Resistance | causes | phenotype | 0.80 |
| lipid metabolism | involves | pathway | 0.80 |
| Immune System | associated_with | process | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GBM | associated_with | gene | 1.00 |
| GLIOBLASTOMA | associated_with | gene | 1.00 |
| EGFR | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| GBM | associated_with | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| GLIOBLASTOMA | regulates | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| GLIOBLASTOMA | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| GBM | therapeutic_target | gene | 1.00 |
| GLIOBLASTOMA | inhibits | gene | 1.00 |
| GLIOBLASTOMA | therapeutic_target | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| GBM | therapeutic_target | gene | 1.00 |
| EGFR | activates | gene | 1.00 |
| IDH1 | associated_with | entity | 0.98 |
| Glioma | activates | disease | 0.95 |
| Pi3K/Akt/Mtor | involved_in | pathway | 0.95 |
| GBM | activates | gene | 0.95 |
| Glioma | associated_with | disease | 0.95 |
| Neurodegeneration | activates | disease | 0.95 |
| Glucocorticoids | modulates | compound | 0.95 |
| MTOR | activates | gene | 0.95 |
| AUTOPHAGY | activates | gene | 0.95 |
| Glioblastoma Stem Cells | involved_in | cell_type | 0.95 |
| GR | regulates | receptor | 0.95 |
| Lipid Metabolism | promotes | pathway | 0.95 |
| PI3K/Akt/mTOR | upregulates | pathway | 0.95 |
| AKT | therapeutic_target | gene | 0.95 |
| PI3K | therapeutic_target | gene | 0.95 |
| Compound 1F | suppresses | compound | 0.95 |
| PI3K | activates | gene | 0.95 |
| IDH2 | associated_with | gene | 0.92 |
| PTEN Deficiency | associated_with | biomarker | 0.90 |
| CAR T cells | treats | cell_type | 0.90 |
| Cranial Bone Marrow | associated_with | brain_region | 0.90 |
| Axonal Injury | associated_with | process | 0.90 |
| GBM | treats | gene | 0.90 |
| Lactate | contributes_to | compound | 0.90 |
| Mt-125 | treats | drug | 0.90 |
| GBM | regulates | gene | 0.90 |
| Lipid Metabolism | contributes_to | pathway | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GLIOBLASTOMA in their description or question text
No additional research found